Disease | Interactor | Mechanism | Effect | References |
---|---|---|---|---|
Prostate cancer | AR | Increase AR expression and stability to promote PC via the PI3K-Akt pathway | Promote proliferation and cell cycle, inhibit apoptosis | |
Breast cancer | MDK | Stabilize MDK to promote angiogenesis and metastasis | Promote VEGF expression and metastasis | [73] |
Lung cancer | MMP14/PPM1B | Enhance PPM1B stability to inhibit NF-κB-dependent chemokine expression | Promote proliferation, migration and invasion, reshape TME | |
Liver cancer | P38/JNK | Inhibit the p38-MAPK pathway to promote HCC progression | Promote proliferation and inhibit apoptosis | [65] |
Multiple myeloma | HMGB1 | Increase HMGB1 expression and induce HMGB1-mediated autophagy | Induce autophagy and drug resistance | [67] |
Cardiac hypertrophy | p300 | Inhibit p300 degradation and promote METTL3 transcription | Promote Ang II-induced cardiac hypertrophy | [51] |
Huntington’s disease | mHTT | Induce autophagy and decrease mHTT-mediated toxicity | Alleviate mHTT-mediated toxicity and induce autophagy | [70] |